Allogene Therapeutics Inc. (ALLO) Insider Acquires $720,000.00 in Stock

Share on StockTwits

Allogene Therapeutics Inc. (NASDAQ:ALLO) insider David D. Chang bought 40,000 shares of the company’s stock in a transaction that occurred on Monday, October 15th. The shares were bought at an average price of $18.00 per share, for a total transaction of $720,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

ALLO opened at $23.40 on Friday. Allogene Therapeutics Inc. has a 52-week low of $21.67 and a 52-week high of $27.72.

Read More: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for Allogene Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allogene Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Internap Corp  Receives $18.00 Consensus Target Price from Analysts
Internap Corp Receives $18.00 Consensus Target Price from Analysts
Moss Coin Reaches Market Capitalization of $10.06 Million
Moss Coin Reaches Market Capitalization of $10.06 Million
Arbutus Biopharma Corp  Expected to Announce Quarterly Sales of $770,000.00
Arbutus Biopharma Corp Expected to Announce Quarterly Sales of $770,000.00
$0.46 Earnings Per Share Expected for Tristate Capital Holdings Inc  This Quarter
$0.46 Earnings Per Share Expected for Tristate Capital Holdings Inc This Quarter
DexCom, Inc.  Expected to Post Quarterly Sales of $283.08 Million
DexCom, Inc. Expected to Post Quarterly Sales of $283.08 Million
E*TRADE Financial Corp  Expected to Announce Earnings of $1.03 Per Share
E*TRADE Financial Corp Expected to Announce Earnings of $1.03 Per Share


© 2006-2018 Ticker Report